BPG is committed to discovery and dissemination of knowledge
Featured Articles
Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease
Browse: 26   Download: 28   Issue Date: 2024-05-27
Current concepts in the management of non-cirrhotic non-malignant portal vein thrombosis
Browse: 23   Download: 20   Issue Date: 2024-05-27
Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?
Browse: 20   Download: 20   Issue Date: 2024-05-27
Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease
Browse: 23   Download: 20   Issue Date: 2024-05-27
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
Browse: 24   Download: 22   Issue Date: 2024-05-27
Expression and clinical significance of short-chain fatty acids in patients with intrahepatic cholestasis of pregnancy
Browse: 63   Download: 134   Issue Date: 2024-04-27
Molecular mechanism of nanomaterials induced liver injury: A review
Browse: 69   Download: 90   Issue Date: 2024-04-27
Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
Browse: 69   Download: 81   Issue Date: 2024-04-27
Subclinical hepatitis E virus genotype 1 infection: The concept of “dynamic human reservoir”
Browse: 61   Download: 106   Issue Date: 2024-04-27
Progress of mitochondrial and endoplasmic reticulum-associated signaling and its regulation of chronic liver disease by Chinese medicine
Browse: 52   Download: 72   Issue Date: 2024-04-27
Comparison of fungal vs bacterial infections in the medical intensive liver unit: Cause or corollary for high mortality?
Browse: 126   Download: 201   Issue Date: 2024-03-27
Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus
Browse: 198   Download: 322   Issue Date: 2024-03-27
Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
Browse: 141   Download: 204   Issue Date: 2024-03-27
Protein succinylation, hepatic metabolism, and liver diseases
Browse: 130   Download: 190   Issue Date: 2024-03-27
Amebic liver abscess: An update
Browse: 123   Download: 195   Issue Date: 2024-03-27
Yinhuang granule alleviates carbon tetrachloride-induced liver fibrosis in mice and its mechanism
Browse: 155   Download: 194   Issue Date: 2024-02-27
Epidemiological survey of cystic echinococcosis in southwest China: From the Qinghai-Tibet plateau extend to the area of Yunnan
Browse: 120   Download: 234   Issue Date: 2024-02-27
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
Browse: 121   Download: 197   Issue Date: 2024-02-27
Non-invasive assessment of esophageal varices: Status of today
Browse: 125   Download: 133   Issue Date: 2024-02-27
Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?
Browse: 124   Download: 229   Issue Date: 2024-02-27